August 13, 2020- Aetion In a recent interview, Kathryn Starzyk, epidemiologist and Head of Real-World Evidence (RWE) at OM1, shared what makes OM1’s data unique, and how she and her team partner with biopharma and health systems to generate RWE that helps researchers better understand patient journeys in disease areas including rheumatology and immunology. Read on[…]
Thu. Sep 10, 2020 2:00 PM – 3:00 PM EDT Register Real-world data (RWD) is playing an increasing role in health care decisions, especially with autoimmune diseases where diagnosis can be difficult and there is no cure. Despite the promises of RWD to improve our understanding of the natural history of these diseases and to[…]
View our poster on Characteristics and Disease Management in a Large Real World Lupus Nephritis Cohort in the U.S. Click to view more!
View our poster on Predictors of Improvement in Tender Joint Counts Among SLE Patients. Click to view more!
Collaboration enables otolaryngologists and researchers to leverage data for real-world evidence, outcomes, and personalized medicine programs BOSTON, May 13, 2020 — OM1, a real-world outcomes and technology company, today announced a strategic partnership with the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) connecting the Foundation’s Reg-entSM clinical data registry to OM1’s real-world data[…]
